Scientists reveal structure of dangerous bacteria's powerful multidrug resistance pump

Sep 22, 2010

A team at The Scripps Research Institute has detailed the structure of a member of the only remaining class of multidrug resistance transporters left to be described. The work has implications for combating dangerous antibiotic resistant strains of bacteria, as well as for developing hardy strains of agricultural crops.

The study was published in an advance, online issue of the journal Nature on September 22, 2010.

"Now with our crystal structure, scientists can for the first time figure out exactly how this transporter works," said the study's senior investigator, Geoffrey Chang, Ph.D., associate professor in the Scripps Research Department of . "This could lead to the design of drugs that evade or inhibit the transporter, or to reengineering the transporter to help some plants grow in soil they can't grow in now."

The protein described in the study, NorM, was found in the virulent bacteria Vibrio cholerae. V. cholerae causes cholera, a disease that affects the small intestine and is a common cause of death in developing nations. The NorM transporter is responsible for widespread resistance to ciprofloxacin and other fluoroquinolones (a broad-spectrum, inexpensive class of antibiotics) and to tigecycline, a new class of drug specifically designed to overcome that .

Importantly, NorM is a member of the multidrug and toxic compound extrusion (MATE) family that is involved in important biological functions across all kingdoms of life. These transporters defend plant, animal, and microbial cells by pumping out before they can have any effect. In addition to antibiotic resistance, MATE transporters are associated with resistance to a commonly used diabetes drug, as well as resistance to anti-inflammatory and anti- arrhythmia agents. In plants, MATE transporters help to neutralize the acidity of soil, directly affecting crop yields worldwide.

"By showing how a key member of the [MATE transporter] family undergoes shape changes during the extrusion process, this work may lead to new ways to block the transporter, with possible applications in medicine and agriculture," said Jean Chin, Ph.D., who oversees this and other structural biology grants at the National Institutes of Health (NIH).

"Herculean Effort"

It took a "Herculean effort" to produce the high-resolution of NorM, Chang noted. The researchers found it was difficult to produce enough protein to work with, and hard to purify the transporter in its natural state.

After the team found a way to produce and purify the protein, the scientists still needed to create crystals to be able to use a technique known as x-ray crystallography to solve its structure. In this method, scientists produce and purify large quantities of a protein that are crystallized. The crystal is then placed in front of a beam of x-rays, which diffract when they strike the atoms in the crystal. Based on the pattern of diffraction, scientists can reconstruct the shape of the original molecule. In this case, though, the NorM crystals were unusually fragile under an x-ray beam.

After many attempts, however, the research team succeeded in producing two crystal structures of the NorM transporter as it sat on the outside surface of V. cholerae. One showed the transporter by itself and the other provided a snapshot of how the pump is powered by sodium ions.

The NorM transporter normally sits, waiting, on the inside of the bacterial cell membrane for toxic chemicals—in this case antibiotics—that seep inside. The protein then changes shape in order to scoop the chemical up, and transport it back through the cell wall to the outside of the bacteria, keeping the bacteria safe from destruction.

The structure of this bacterial pump revealed a shape distinct from all other MDR transporter families, say co-authors Xiao He and Paul Szewczyk, graduate students at the University of San Diego, California, (UCSD) who worked with Chang to derive the structure. The pair also took the lead in the effort to verify the - a process of labeling 16 different amino acids on the protein and confirming their three-dimensional position. This part of the effort took 18 months.

On the outside of the bacteria, the transporter looks like an upside down "V" shaped lampshade, He said, and the chemical to be removed presumably fits inside the narrow part of the structure. She adds that the research team is working to crystallize the transporter on the inside of the bacterium, as well as the structure with a chemical bound to it.

"Bacteria have a number of different transporter systems, so it is important to design antibiotics that will not be instantly pumped out," He noted.

With the atomic structure of NorM solved, the team continues to investigate other MATE transporters, including those found in plants and those that exist in human liver and kidney cells that can reduce the effectiveness of a wide variety of drugs.

Explore further: The malaria pathogen's cellular skeleton under a super-microscope

Related Stories

Sweet as can be: How E. coli gets ahead

Nov 12, 2009

Scientists at the University of York have discovered how certain bacteria such as Escherichia coli have evolved to capture rare sugars from their environment giving them an evolutionary advantage in naturally competitive enviro ...

High-Res View of Zinc Transport Protein

Sep 13, 2009

( -- How much difference can a tenth of a nanometer make? When it comes to figuring out how proteins work, an improvement in resolution of that miniscule amount can mean the difference between seeing where atoms ...

The structure of resistance

Feb 22, 2008

A team of scientists from the University Paris Descartes has solved the structure of two proteins that allow bacteria to gain resistance to multiple types of antibiotics, according to a report in EMBO reports this month. ...

Protein on 'speed' linked to ADHD

Jul 08, 2008

A genetic change in the dopamine transporter – one of the brain's dopamine-handling proteins – makes it behave as if amphetamine is present and "run backward," Vanderbilt University Medical Center investigators report ...

Sowing seed on salty ground

Jun 06, 2007

Scientists have discovered a gene that allows plants to grow better in low nutrient conditions and even enhance their growth through sodium uptake, according to a report published online this week in The EMBO Journal.

Recommended for you

For resetting circadian rhythms, neural cooperation is key

18 hours ago

Fruit flies are pretty predictable when it comes to scheduling their days, with peaks of activity at dawn and dusk and rest times in between. Now, researchers reporting in the Cell Press journal Cell Reports on April 17th h ...

Rapid and accurate mRNA detection in plant tissues

20 hours ago

Gene expression is the process whereby the genetic information of DNA is used to manufacture functional products, such as proteins, which have numerous different functions in living organisms. Messenger RNA (mRNA) serves ...

For cells, internal stress leads to unique shapes

Apr 16, 2014

From far away, the top of a leaf looks like one seamless surface; however, up close, that smooth exterior is actually made up of a patchwork of cells in a variety of shapes and sizes. Interested in how these ...

User comments : 0

More news stories

Scientists tether lionfish to Cayman reefs

Research done by U.S. scientists in the Cayman Islands suggests that native predators can be trained to gobble up invasive lionfish that colonize regional reefs and voraciously prey on juvenile marine creatures.

Deadly human pathogen Cryptococcus fully sequenced

Within each strand of DNA lies the blueprint for building an organism, along with the keys to its evolution and survival. These genetic instructions can give valuable insight into why pathogens like Cryptococcus ne ...

Leeches help save woman's ear after pit bull mauling

(HealthDay)—A pit bull attack in July 2013 left a 19-year-old woman with her left ear ripped from her head, leaving an open wound. After preserving the ear, the surgical team started with a reconnection ...

Venture investments jump to $9.5B in 1Q

Funding for U.S. startup companies soared 57 percent in the first quarter to a level not seen since 2001, as venture capitalists piled more money into an increasing number of deals, according to a report due out Friday.